The last ASX announcement made the following points...................(1) CORIS® - Continue to target FDA regulatory submission by end Q3 FY24
(2)
Despite the market challengesfaced in the first half, we expect both unit and revenue growth in H2 over H1.We remain confident in the ongoing growth opportunity of the Company's trophonultrasound reprocessing business as well as the broader growth opportunitiesthrough the investments being made in both product and geographicalexpansion."
NAN Chart, page-162
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.81 |
Change
0.090(3.31%) |
Mkt cap ! $851.3M | |||
| Open | High | Low | Value | Volume |
| $2.75 | $2.81 | $2.72 | $3.690M | 1.321M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4654 | $2.79 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.81 | 12545 | 3 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.80 |
Change
0.090 ( 2.93 %) |
||||
| Open | High | Low | Volume | ||
| $2.75 | $2.80 | $2.72 | 144123 | ||
| Last updated 15.59pm 31/05/2024 ? | |||||
| NAN (ASX) Chart |